ZEC Falls 33% in Two Days as First ZEC DAT Campaign Launches; Leap Therapeutic Rebrands
Zcash tumbled about 33% in two days as the community kicked off the first ZEC DAT campaign. The launch, intended to advance the protocol's rollout and community initiatives, appears to have met with heavy selling pressure and short-term profit-taking, highlighting heightened volatility around nascent adoption events. Traders and observers are watching on-chain metrics and campaign participation as immediate indicators of whether demand will recover.
Separately, Nasdaq-listed Leap Therapeutic disclosed a $58.9 million private investment from Winklevoss Capital and has changed its name to Cypherpunk Technologies to signal a strategic pivot toward Zcash. The cash infusion and high-profile backer add legitimacy but also invite regulatory and market scrutiny, since a public company shifting from biotech to privacy crypto is an unusual move. The combined developments make the near-term direction for ZEC dependent on campaign uptake, liquidity flows, and any regulatory reactions.